Literature DB >> 7627625

Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction.

A E Ades1.   

Abstract

To examine the potential role of seroprevalence surveys in HIV epidemic analysis and prediction, seroprevalence was modeled in terms of age- and time-specific incidence, while taking account of the differential inclusion of infected and uninfected individuals in serosurveys. Differential inclusion had two components, one reflecting disease progression and the other background demographic factors that could change over time. Seroprevalence and progression marker data generated by simulated epidemics showed that age dependence in HIV incidence is a key factor in data interpretation. Time trends in seroprevalence are difficult to interpret, and incidence cannot be estimated from these data unless the effects of disease progression on inclusion are taken into account. Furthermore, changes in incidence could be hard to distinguish from changes in background differential inclusion, casting doubt on the value of smaller sentinel surveys. Uncertainty about differential inclusion severely limits the value of seroprevalence data in improving the precision of HIV/AIDS prediction. Progression marker data are even harder to interpret, since changes in incidence will have effects on the marker value distribution, the size, direction, and timing of which are highly age-dependent. Independent data on differential inclusion would enhance the value of data from seroprevalence surveys.

Entities:  

Mesh:

Year:  1995        PMID: 7627625

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  6 in total

1.  Trends in undiagnosed HIV-1 infection among attenders at genitourinary medicine clinics, England, Wales, and Northern Ireland: 1990-6.

Authors:  I Simms; P Rogers; M Catchpole; C A McGarrigle; A Nicoll
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

2.  Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.

Authors:  Timothy D Mastro; Andrea A Kim; Timothy Hallett; Thomas Rehle; Alex Welte; Oliver Laeyendecker; Tom Oluoch; Jesus M Garcia-Calleja
Journal:  J HIV AIDS Surveill Epidemiol       Date:  2010-01-01

3.  Impact of incomplete coverage of neonatal dried blood spot screening on estimating HIV-1 seroprevalence.

Authors:  E J Hutchinson; A Streetly; C Grant; R Pollitt; P Eldridge; A Nicoll
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

4.  A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.

Authors:  Guy Severin Mahiane; Rachid Ouifki; Hilmarie Brand; Wim Delva; Alex Welte
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

5.  Estimating incidence from prevalence in generalised HIV epidemics: methods and validation.

Authors:  Timothy B Hallett; Basia Zaba; Jim Todd; Ben Lopman; Wambura Mwita; Sam Biraro; Simon Gregson; J Ties Boerma
Journal:  PLoS Med       Date:  2008-04-08       Impact factor: 11.069

6.  Estimation of HIV incidence in two Brazilian municipalities, 2013.

Authors:  Célia Landmann Szwarcwald; Orlando da Costa Ferreira; Ana Maria de Brito; Karin Regina Luhm; Clea Elisa Lopes Ribeiro; Ana Maria Silva; Ana Maria Salustiano Cavalcanti; Tomoko Sasazawa Ito; Sonia Mara Raboni; Paulo Roberto Borges de Souza; Gerson Fernando Mendes Pereira
Journal:  Rev Saude Publica       Date:  2016-09-01       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.